Transient perforating folliculitis induced by sorafenib

Journal of Dermatology

Volumn 37, Issue 9, 2010, Pages 833-834

  Minami Hori, Masako ^a   Ishida Yamamoto, Akemi ^a   Komatsu, Shigetsuna ^a   Iiduka, Hajime ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; SORAFENIB;

AGED; ANGIOGENESIS; CASE REPORT; CELL VACUOLE; CORTICOSTEROID THERAPY; DYSKERATOSIS; EPITHELIUM CELL; FOLLICULITIS; FOLLICULITIS PERFORANS; HAIR LOSS; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; JAPANESE; KERATINOCYTE; KIDNEY CARCINOMA; KIDNEY METASTASIS; LETTER; LYMPHOCYTIC INFILTRATION; MALE; NEUTROPHIL CHEMOTAXIS; PAPULE; PIGMENTATION;

AGED; ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CARCINOMA, RENAL CELL; FOLLICULITIS; HUMANS; KIDNEY NEOPLASMS; MALE; NEUTROPHIL INFILTRATION; PROTEIN KINASE INHIBITORS; PYRIDINES; REMISSION, SPONTANEOUS;

EID: 77956204115     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00885.x     Document Type: Letter

References (4)

1. Ratain MJ, Eisen T, Stadler WM et al. Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol 2006 24 : 2505 2512.
2. Wolber C, Udvardi A, Tatzreiter G, Schneeberger A, Volc-Platzer B. Perforating folliculitis, angioedema, hand-foot syndrome- multiple cutaneous side effects in a patient treated with sorafenib. J Dtsch Dermatol Ges 2009 5 : 449 452.
3. Kong HH, Terner ML. Array of cutaneous adverse effects associated with sorafenib. J Am Acad Dermatol 2009 61 : 360 361.
4. Lopez V, Piazo I, Marti N, Monteagudo C, Jorda E. Follicular hyperplasia on the face subsequent to therapy with sorafenib. A new skin side effect. J Eur Acad Dermatol Venereol 2009 8 : 959 960.